India judges a leading hospital by growth, margins and an IPO exit.
Part 1 of our Healthcare team's November newsletter looks at how the top 20 global institutions are evaluated.
The answer goes well beyond financials.
Read here: shorturl.at/As7C6
133
India is entering its Golden Decade of consumption, & value retail is a major consumer bet. Superior quality at value pricing is how scaled players win.
Our Consumer team's October newsletter explores the global playbook & who wins in India.
Read here: shorturl.at/ggXmt
119
Indian agri-tech does not have an adoption problem. It has a margin problem.
Our Digital team's October Sector Note maps the sector, from farm inputs to farm to consumer.
After the funding reset, capital is backing models that earn a return.
Read here: shorturl.at/VTC5l
1
127
In Indian precision engineering, capacity is no longer the differentiator.
Our Industrials team's October newsletter looks at what the market now rewards across its three cohorts, and where capital is flowing next.
Read here: shorturl.at/BIwJN
1
116
In utilities tech, demand for specialized capabilities is outpacing talent supply
Our Technology team's October newsletter maps gaps-from grid engineering to OT cybersecurity
Utilities IT spending grows faster than overall IT spending
Read here: shorturl.at/dSl0N
140
Demand in Indian housing finance remains strong, but lenders face challenges in scaling up.
The latest FIG newsletter looks at 40+ HFCs that account for a fifth of India’s housing credit & how borrowing & operating costs affect their prospects
Read here: shorturl.at/HWnXu
India's API industry is moving from scale to complexity. Markets already pay a premium to those making the shift.
Our Life Sciences team's latest newsletter discusses how carve-outs, PE roll-ups and CDMO pivots are building API champions.
Read here: shorturl.at/t0b7f
India's hospital deals have moved from minority bets to control.
Our Healthcare team's latest report tracks a ~17x surge in deal value over two decades.
PE roll-ups and strategic buyouts are concentrating capital in fewer, larger platforms.
Read here: shorturl.at/7TCYq
1
174
India's credit gap is an infrastructure problem, not a demand problem.
Digital team's latest newsletter maps the lending-tech stack, from co-lending to collections.
Full-stack platforms are best placed to win as lending turns partnership-led.
Read here: shorturl.at/GBZWA
168
Our Managing Partner Shiraz Bugwadia spoke at the recent Danaher Growth Conference centred around the theme “Leading Tech-Enabled Growth in a Disrupted World.”
With scale and technology reshaping the sector, healthcare continues to be an area of deep focus for o3 Capital.
IT services M&A has entered a new phase
Our Tech team's September note leads with the ITC Infotech <> Happiest Minds merger: creating a $1 billion AI-first platform
AI disruption and valuation reset are pulling strategics into consolidation
Read here: shorturl.at/3pFLA
281
Family Day 2026 edition brought our families together at Mumbai and Bengaluru for a day of laughter, shared memories, happy conversations and a peek into life at o3.
A big thank you to our constants - your energy makes o3 possible. We loved having you around!
#o3DealAlert | o3 Capital advised Koye Pharmaceuticals on its acquisition by Integrace, a Warburg Pincus-backed domestic formulations platform
3rd transaction with Koye. 2nd supporting Warburg’s platform build-out. 9th in domestic formulations
Read here: shorturl.at/EJRXZ
2
218
India’s ice-cream industry is growing rapidly, but the bigger story is the structural change happening underneath.
From distribution and premiumisation to consolidation and capital, the category is heating up.
Read our Consumer team's Spotlight here: shorturl.at/1UQcI
2
179
Indian life sciences has proven it can build. The real question now: can it scale?
That anchored the third edition of o3 CONVERGENCE — 22 founders, 30 funds, 125+ meetings charting the next phase of the pharma story.
A big thank you to everyone who made it a success!
186
o3 Capital advised @rpglifesciences & InvAscent on the acquisition of Raghava Life Sciences’ API & intermediates business.
Our 2nd transaction with RPG Life Sciences & InvAscent in 45 days, and 14th Life Sciences & Healthcare deal in 2 years.
Read here: shorturl.at/ezb0A
We are pleased to welcome Pranav Ghodke as Head – Human Resources at o3 Capital
At o3 Capital, building the institution goes hand in hand with nurturing great teams. We look forward to Pranav leading this agenda and shaping the next chapter of our people journey
Welcome Pranav!
🤖 Made with AI
168
We hosted Rahul Mukim for an engaging conversation on institutional capital, investing discipline and building businesses
His advice to young bankers: keep learning, earn trust, handle pressure, and never stop building relationships
Thank you, Rahul, for an insightful session!
UPI has solved for scale. Can it now solve for sustainability?
Our latest Digital Newsletter explores the MDR question and what a calibrated model could mean for the economics of India’s payments ecosystem.
UPI 2.0: The MDR Question
Read here: shorturl.at/fqP4w
IVF and Mother & Childcare are part of one patient journey.
The next opportunity may lie in integrated platforms that acquire through IVF, retain through OBGYN and monetise through delivery and pediatrics.
Read our Healthcare team's newsletter for Aug: shorturl.at/Nuw1y
1
180

























